- Home
- WEA vs CBUS Comparison
WEA vs CBUS Comparison
Compare WEA & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WEA | CBUS |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.2M | 121.1M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | WEA | CBUS |
|---|---|---|
| Price | $10.37 | $1.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 32.1K | ★ 359.2K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 7.87% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.30 | $1.09 |
| 52 Week High | $11.44 | $4.19 |
Technical Indicators
Market Signals| Indicator | WEA | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 30.15 | 36.76 |
| Support Level | $10.30 | $1.21 |
| Resistance Level | $11.39 | $1.50 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 6.29 | 18.60 |
Price Performance
Historical ComparisonAbout WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.